More than half of the topical antifungal prescriptions in the United States in 2023 may have been unnecessary, and only 16% ...

There is an urgent need for multicenter, well-defined, comparative clinical trials evaluating the effectiveness and tolerability of combined antifungal therapy in all ages, particularly in children.